Overbrook Management Corp

Position in PGEN — Precigen, Inc.

CIK 1269786 NEW YORK, NY

Position in PGEN

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$171,000

New position

Shares Held

30,000

first reported quarter

Ownership

0.008%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#131

of 208 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Overbrook Management Corp holds $2,742,613 across 3 Biotechnology names. PGEN ranks #3 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	38,208	$2,142,322
2	CLDX	Celldex Therapeutics, Inc.	11,537	$429,291
3	PGEN	Precigen, Inc. This page	30,000	$171,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$171,000	30,000	—	Shares	Sole	2026-07-30
No filing history on record for this holder in this stock.